Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market By: Benzinga via Benzinga January 06, 2015 at 12:21 PM EST The biotech sector's expected 2015 earnings growth of 19 percent will far outpace the broader market while drug reimbursement ... Read More >> Related Stocks: Gilead Sciences